BTAI
BioXcel Therapeutics, Inc.Company with tickers: BTAI
Market Cap
$40.45M
Shares Outstanding
30,877,605
CIK
1720893
CUSIP
09075P204
13F Activity (30d)
1 filings
1 filers
Website
Visit website
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-27 | BioXcel Therapeutics KOL Virtual Roundtable Day | Event |
| 2025-12-08 | KOL Video -Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions | Event |
| 2025-09-10 | Bioxcel Therapeutics SERENITY At-Home Pivotal Phase 3 Safety Trial Results | Event |
| 2025-09-08 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-08-27 | Conference call to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL501 | Conference |
| 2025-08-14 | H.C. Wainwright & Co. “HCW@Home” series | Event |
| 2025-08-12 | Canaccord Genuity 45th Annual Growth Conference | Conference |
| 2024-11-14 | Third Quarter 2024 Financial Results | Event |
| 2024-10-30 | ThinkEquity Conference | Conference |
| 2024-08-13 | Canaccord Genuity 44th Annual Growth Conference | Conference |